We are live on
!
Find out more
Two Sigma Advisers Portfolio holdings
AUM
$51.4B
1-Year Est. Return
31.07%
This Fund
S&P 500
This Quarter
Est. Return
-3.02%
1 Year Est. Return
+31.07%
3 Year Est. Return
+128.94%
5 Year Est. Return
+161.75%
10 Year Est. Return
+607.04%
AUM
$34.5B
AUM Growth
-$708M
(-2%)
Cap. Flow
+$1.23B
Cap. Flow
% of AUM
3.55%
Top 10 Holdings %
Top 10 Hldgs %
13.77%
Holding
2,852
New
233
Increased
919
Reduced
1,343
Closed
332
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Enphase Energy
ENPH
|
+$342M |
| 2 |
Intel
INTC
|
+$276M |
| 3 |
TSMC
TSM
|
+$237M |
| 4 |
Procter & Gamble
PG
|
+$178M |
| 5 |
JPMorgan Chase
JPM
|
+$170M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Netflix
NFLX
|
+$383M |
| 2 |
Occidental Petroleum
OXY
|
+$321M |
| 3 |
PayPal
PYPL
|
+$316M |
| 4 |
S&P Global
SPGI
|
+$145M |
| 5 |
Datadog
DDOG
|
+$133M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.57% |
| 2 | Healthcare | 17.95% |
| 3 | Financials | 9.89% |
| 4 | Industrials | 9.61% |
| 5 | Consumer Discretionary | 7.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1076
Allogene Therapeutics
ALLO
$573M
| $2.4M | 0.01% |
222,500
+90,000
| +68% | +$1.22M |
|
1077
Wintrust Financial
WTFC
$10.9B
| $2.4M | 0.01% |
29,400
-29,200
| -50% | -$2.48M |
|
1078
DaVita
DVA
$15.4B
| $2.39M | 0.01% |
28,832
-103,400
| -78% | -$9.07M |
|
1079
C4 Therapeutics
CCCC
$393M
| $2.38M | 0.01% |
271,600
-77,900
| -22% | -$809K |
|
1080
ARKO Corp
ARKO
$901M
| $2.38M | 0.01% |
253,300
+153,800
| +155% | +$1.46M |
|
|
ROCC
1081
DELISTED
Ranger Oil Corporation Class A Common Stock
ROCC
| $2.38M | 0.01% |
75,600
-138,200
| -65% | -$4.87M |
|
1082
Waste Management
WM
$96.1B
| $2.37M | 0.01% |
14,800
-21,700
| -59% | -$3.58M |
|
1083
Horizon Technology Finance
HRZN
$295M
| $2.37M | 0.01% |
236,397
-45,500
| -16% | -$560K |
|
1084
Southern Copper
SCCO
$140B
| $2.37M | 0.01% |
56,911
-21,898
| -28% | -$969K |
|
|
BHR
1085
Braemar Hotels & Resorts
BHR
$160M
| $2.36M | 0.01% |
549,156
+70,700
| +15% | +$359K |
|
|
THR
1086
DELISTED
Thermon Group Holdings
THR
| $2.36M | 0.01% |
153,162
+61,300
| +67% | +$1.01M |
|
1087
Cracker Barrel
CBRL
$1.2B
| $2.35M | 0.01% |
25,402
+13,600
| +115% | +$1.37M |
|
1088
Mirum Pharmaceuticals
MIRM
$6.84B
| $2.35M | 0.01% |
111,900
-46,100
| -29% | -$1.11M |
|
|
HCCI
1089
DELISTED
Heritage-Crystal Clean, Inc.
HCCI
| $2.34M | 0.01% |
78,983
-1,500
| -2% | -$46.9K |
|
1090
Carpenter Technology
CRS
$27.8B
| $2.33M | 0.01% |
74,800
-5,600
| -7% | -$185K |
|
1091
SITE Centers
SITC
$235M
| $2.32M | 0.01% |
277,883
-47,169
| -15% | -$493K |
|
|
MRUS
1092
DELISTED
Merus
MRUS
| $2.32M | 0.01% |
115,900
-6,600
| -5% | -$157K |
|
1093
LiveRamp
RAMP
$2.29B
| $2.32M | 0.01% |
127,800
+113,600
| +800% | +$2.63M |
|
1094
Super Micro Computer
SMCI
$18.4B
| $2.32M | 0.01% |
421,000
+112,000
| +36% | +$638K |
|
1095
nLIGHT
LASR
$3.57B
| $2.31M | 0.01% |
244,900
+107,200
| +78% | +$1.24M |
|
1096
Immersion
IMMR
$254M
| $2.31M | 0.01% |
421,400
-17,500
| -4% | -$98.6K |
|
1097
Jakks Pacific
JAKK
$305M
| $2.31M | 0.01% |
119,460
+100,600
| +533% | +$2.07M |
|
1098
Sempra
SRE
$59.2B
| $2.31M | 0.01% |
+30,800
| New | +$2.49M |
|
1099
Fabrinet
FN
$16.1B
| $2.3M | 0.01% |
24,100
-1,400
| -5% | -$135K |
|
1100
Rigel Pharmaceuticals
RIGL
$712M
| $2.3M | 0.01% |
194,829
+163,270
| +517% | +$2.21M |
|
Similar funds
CWM
VRS
FAF
BGIM
CIM
PPFA
Two Sigma Advisers's Q3 2022 Portfolio in Review
As of Q3 2022, Two Sigma Advisers held 2,852 positions worth $34.5B, down 2% from $35.3B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Two Sigma Advisers deployed $1.23B of net new capital in Q3 2022, opening 233 new positions and adding to 919 existing holdings. Its largest new stake was State Street SPDR S&P Biotech ETF: 1,329,800 shares worth $105M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 24% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Netflix, an estimated $383M trimmed.
- Two Sigma Advisers's largest Q3 2022 buy was State Street SPDR S&P Biotech ETF: 1,329,800 shares worth $105M.
- Two Sigma Advisers added most to Enphase Energy in Q3 2022, an estimated $342M increase.
- Two Sigma Advisers's biggest Q3 2022 reduction was Netflix, cutting an estimated $383M.
- Two Sigma Advisers fully exited S&P Global in Q3 2022, selling an estimated $145M.
- Two Sigma Advisers's ten largest holdings make up 14% of its $34.5B portfolio in Q3 2022.
- Two Sigma Advisers opened 233 new positions and closed 332 in Q3 2022.
- Two Sigma Advisers's portfolio value fell 2% quarter-over-quarter to $34.5B.
Based on Two Sigma Advisers's 13F filing for Q3 2022, filed 14 Nov 2022.